Sunshine Biopharma (SBFM) Other Working Capital Changes (2016 - 2026)
Sunshine Biopharma filings provide 13 years of Other Working Capital Changes readings, the most recent being -$189082.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 141.23% to -$189082.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$480798.0, a 332.08% decrease, with the full-year FY2025 number at -$480798.0, down 332.08% from a year prior.
- Other Working Capital Changes hit -$189082.0 in Q4 2025 for Sunshine Biopharma, down from -$36168.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $568981.0 in Q1 2024 to a low of -$736637.0 in Q2 2024.
- Median Other Working Capital Changes over the past 5 years was -$21720.0 (2021), compared with a mean of -$12443.0.
- The widest YoY moves for Other Working Capital Changes: up 4490.14% in 2023, down 1541.65% in 2023.
- Sunshine Biopharma's Other Working Capital Changes stood at -$22268.0 in 2021, then soared by 126.33% to $5863.0 in 2022, then skyrocketed by 4490.14% to $269120.0 in 2023, then soared by 70.39% to $458558.0 in 2024, then crashed by 141.23% to -$189082.0 in 2025.
- The last three reported values for Other Working Capital Changes were -$189082.0 (Q4 2025), -$36168.0 (Q3 2025), and -$115617.0 (Q2 2025) per Business Quant data.